NicVAX

a nicotine vaccine

Also Known As:

3'-aminomethylnicotine Pseudomonas aeruginosa r-exoprotein A; 3'AmNic-rEPA

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Milnerowicz, Halina: 1 article (07/2014)
2.	Sliwińska-Mossoń, Mariola: 1 article (07/2014)
3.	Zieleń, Iwona: 1 article (07/2014)
4.	Heading, Christine E: 1 article (12/2003)

1.	Tobacco Use Disorder (Nicotine Dependence) 12/01/2003 - "Nabi Biopharmaceuticals is developing NicVAX, a proprietary vaccine designed as a potential therapeutic to prevent and treat nicotine addiction." 07/01/2014 - "An interesting proposal to combat nicotine addiction are vaccines--NicVAX, CYT002-NicQb and TA-NIC. "